We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+676.14%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.17%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.66T
$50.3B 6.36%
195,859,819
+556,020
+0.3% +$151M
AMZN icon
2
Amazon
AMZN
$2.99T
$33.1B 4.19%
311,971,394
-9,855,486
-3% -$1.23B
AAPL icon
3
Apple
AAPL
$4.52T
$32.5B 4.11%
237,910,783
+4,831,418
+2% +$732M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.59T
$23.8B 3.01%
217,557,340
-25,139,540
-10% -$2.97B
UNH icon
5
UnitedHealth
UNH
$370B
$18.9B 2.39%
36,853,394
+5,556,335
+18% +$2.79B
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.62T
$13.6B 1.72%
124,910,820
-692,140
-0.6% -$81.5M
V icon
7
Visa
V
$690B
$10.1B 1.28%
51,261,821
+200,057
+0.4% +$41.3M
TSLA icon
8
Tesla
TSLA
$1.29T
$9.58B 1.21%
42,699,258
+3,953,061
+10% +$1.08B
NVDA icon
9
NVIDIA
NVDA
$5.13T
$8.63B 1.09%
569,298,190
+38,004,870
+7% +$717M
MA icon
10
Mastercard
MA
$500B
$8.49B 1.07%
26,909,008
+3,102,135
+13% +$1.07B
META icon
11
Meta Platforms (Facebook)
META
$1.5T
$8.33B 1.05%
51,634,675
-23,026,442
-31% -$4.44B
CRM icon
12
Salesforce
CRM
$156B
$7.71B 0.97%
46,707,038
+13,483,854
+41% +$2.38B
TMO icon
13
Thermo Fisher Scientific
TMO
$209B
$6.93B 0.88%
12,746,817
-1,784,259
-12% -$982M
INTU icon
14
Intuit
INTU
$88.5B
$6.84B 0.86%
17,749,565
+575,174
+3% +$238M
DHR icon
15
Danaher
DHR
$137B
$6.7B 0.85%
29,828,098
-1,859,679
-6% -$428M
NOW icon
16
ServiceNow
NOW
$122B
$6.67B 0.84%
70,089,390
-996,040
-1% -$94.9M
LLY icon
17
Eli Lilly
LLY
$995B
$6.62B 0.84%
20,426,658
-498,109
-2% -$150M
BDX icon
18
Becton Dickinson
BDX
$46.9B
$6.61B 0.84%
26,814,411
+13,644,193
+104% +$3.46B
AZN icon
19
AstraZeneca
AZN
$241B
$5.68B 0.72%
42,959,898
-4,155,037
-9% -$545M
GE icon
20
GE Aerospace
GE
$391B
$5.32B 0.67%
134,164,039
-47,450,279
-26% -$2.3B
ASML icon
21
ASML
ASML
$658B
$5.23B 0.66%
10,991,878
-517,235
-4% -$289M
ISRG icon
22
Intuitive Surgical
ISRG
$130B
$5.16B 0.65%
25,692,735
+816,066
+3% +$191M
ROP icon
23
Roper Technologies
ROP
$38.8B
$4.75B 0.6%
12,028,540
+462,988
+4% +$201M
ABBV icon
24
AbbVie
ABBV
$431B
$4.72B 0.6%
30,807,798
-5,924,329
-16% -$905M
DG icon
25
Dollar General
DG
$28.1B
$4.64B 0.59%
18,907,932
-425,457
-2% -$99.3M

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.